Masayuki Isaji

This inventor holds 38 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents, primarily in Medicinal Chemistry. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2000-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Isaji. Retrieved from https://idiyas.com/inventor/masayuki-isaji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38

% Patents Active = 44.7

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 376(Granted Patents)

Location History:

Shiojiri, JP (2007)
Hotaka-machi, JP (2008 - 2009)
Nagano, JP (2000 - 2015)
Azumino, JP (2008 - 2017)

Company Filing History:

38 out of 176

Kissei Pharmaceutical Co., Ltd.

patents

Years Active: 2000-2017

Loading Chart...

Areas of Expertise:

Pyrazole Derivatives

Fused Heterocycles

Medicinal Compositions

Nitrogenous Derivatives

Glucopyranosyloxy Compounds

Disease Inhibitors

Secondary Cataract

Neovascularization

Liver Fat Accumulation

Pterygium Treatment

Drug Production

Medical Uses

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9694027 - Pyrazole derivative and use thereof for medical purposes (2017-07-04),

2. 9273085 - Pyrazole derivative and use thereof for medical purposes (2016-03-01),

3. 8951976 - Progression inhibitor for disease attributed to abnormal accumulation of liver fat (2015-02-10),

4. 8324176 - Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof (2012-12-04),

5. 8058245 - Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof (2011-11-15),

6. 7998975 - Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs (2011-08-16),

7. 7989424 - Glucopyranosyloxypyrazole derivatives and use thereof in medicines (2011-08-02),

8. 7888487 - Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same (2011-02-15),

9. 7732596 - Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof (2010-06-08),

10. 7655633 - Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof (2010-02-02),

11. 7655632 - Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof (2010-02-02),

12. 7635684 - Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof (2009-12-22),

13. 7576064 - Pyrazole derivative, drug composition containing the same and production intermediate therefor (2009-08-18),

14. 7576063 - Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same (2009-08-18),

15. 7566699 - Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof (2009-07-28),

Title: Unveiling the Innovations of Masayuki Isaji in Medical Pharmaceuticals

Introduction:

Masayuki Isaji, a brilliant inventor based in Nagano, Japan, has made significant contributions to the field of medical pharmaceuticals. With 38 patents to his name, he has been a pioneering force in the development of innovative solutions for various medical conditions.

Latest Patents:

Among his recent patents is the groundbreaking invention of a Pyrazole derivative for medical purposes. This invention focuses on pharmaceuticals that are designed to prevent or treat constipation effectively. The active ingredient, 3-(3-{4-[3-(β-D-glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide, has shown promising results in increasing bowel movement frequency, offering a valuable solution for individuals suffering from constipation.

Career Highlights:

Masayuki Isaji has honed his expertise at Kissei Pharmaceutical Co., Ltd., a renowned pharmaceutical company known for its innovative research and development initiatives. His tenure at Kissei Pharmaceutical Co., Ltd. has provided him with a platform to translate his inventive ideas into tangible solutions that benefit society.

Collaborations:

In his professional journey, Masayuki Isaji has had the privilege of collaborating with esteemed colleagues such as Hideki Fujikura and Nobuhiko Fushimi. Together, they have worked tirelessly to bring cutting-edge pharmaceutical innovations to fruition, further solidifying their collective impact on the field.

Conclusion:

In conclusion, Masayuki Isaji's relentless pursuit of innovation in medical pharmaceuticals has not only earned him recognition but has also positively impacted the lives of many individuals. His inventive spirit, coupled with his dedication to addressing critical medical needs, underscores his invaluable contribution to the realm of health sciences.

Profile summary based on public USPTO records.